Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1991 Dec;44(12):979–982. doi: 10.1136/jcp.44.12.979

Wiskott-Aldrich syndrome: a multidisciplinary disease.

G R Standen 1
PMCID: PMC494964  PMID: 1791213

Full text

PDF
979

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALDRICH R. A., STEINBERG A. G., CAMPBELL D. C. Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. Pediatrics. 1954 Feb;13(2):133–139. [PubMed] [Google Scholar]
  2. Akkerman J. W., van Brederode W., Gorter G., Zegers B. J., Kuis W. The Wiskott-Aldrich syndrome: studies on a possible defect in mitochondrial ATP resynthesis in platelets. Br J Haematol. 1982 Aug;51(4):561–568. doi: 10.1111/j.1365-2141.1982.tb02819.x. [DOI] [PubMed] [Google Scholar]
  3. Arveiler B., de Saint-Basile G., Fischer A., Griscelli C., Mandel J. L. Germ-line mosaicism simulates genetic heterogeneity in Wiskott-Aldrich syndrome. Am J Hum Genet. 1990 May;46(5):906–911. [PMC free article] [PubMed] [Google Scholar]
  4. Buckley R. H. Advances in the correction of immunodeficiency by bone marrow transplantation. Pediatr Ann. 1987 May;16(5):412-3, 416-21. doi: 10.3928/0090-4481-19870501-09. [DOI] [PubMed] [Google Scholar]
  5. Canales M. L., Mauer A. M. Sex-linked hereditary thrombocytopenia as a variant of Wiskott-Aldrich syndrome. N Engl J Med. 1967 Oct 26;277(17):899–901. doi: 10.1056/NEJM196710262771703. [DOI] [PubMed] [Google Scholar]
  6. Cooper M. D., Chae H. P., Lowman J. T., Krivit W., Good R. A. Wiskott-Aldrich syndrome. An immunologic deficiency disease involving the afferent limb of immunity. Am J Med. 1968 Apr;44(4):499–513. doi: 10.1016/0002-9343(68)90051-x. [DOI] [PubMed] [Google Scholar]
  7. Corash L., Shafer B., Blaese R. M. Platelet-associated immunoglobulin, platelet size, and the effect of splenectomy in the Wiskott-Aldrich syndrome. Blood. 1985 Jun;65(6):1439–1443. [PubMed] [Google Scholar]
  8. DeSanto N. G., Sessa A., Capodicasa G., Meroni M., Capasso G., Esposito L., Ferrara M., Torri Tarelli L., Annunziata S., Giordano C. IgA glomerulonephritis in Wiskott-Aldrich syndrome. Child Nephrol Urol. 1988;9(1-2):118–120. [PubMed] [Google Scholar]
  9. Donnér M., Schwartz M., Carlsson K. U., Holmberg L. Hereditary X-linked thrombocytopenia maps to the same chromosomal region as the Wiskott-Aldrich syndrome. Blood. 1988 Dec;72(6):1849–1853. [PubMed] [Google Scholar]
  10. Fearon E. R., Kohn D. B., Winkelstein J. A., Vogelstein B., Blaese R. M. Carrier detection in the Wiskott Aldrich syndrome. Blood. 1988 Nov;72(5):1735–1739. [PubMed] [Google Scholar]
  11. Fischer A., Friedrich W., Fasth A., Blanche S., Le Deist F., Girault D., Veber F., Vossen J., Lopez M., Griscelli C. Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: a European Group for Immunodeficiency/European Group for Bone Marrow Transplantation report. Blood. 1991 Jan 15;77(2):249–256. [PubMed] [Google Scholar]
  12. Greer W. L., Higgins E., Sutherland D. R., Novogrodsky A., Brockhausen I., Peacocke M., Rubin L. A., Baker M., Dennis J. W., Siminovitch K. A. Altered expression of leucocyte sialoglycoprotein in Wiskott-Aldrich syndrome is associated with a specific defect in O-glycosylation. Biochem Cell Biol. 1989 Sep;67(9):503–509. doi: 10.1139/o89-081. [DOI] [PubMed] [Google Scholar]
  13. Greer W. L., Kwong P. C., Peacocke M., Ip P., Rubin L. A., Siminovitch K. A. X-chromosome inactivation in the Wiskott-Aldrich syndrome: a marker for detection of the carrier state and identification of cell lineages expressing the gene defect. Genomics. 1989 Jan;4(1):60–67. doi: 10.1016/0888-7543(89)90315-7. [DOI] [PubMed] [Google Scholar]
  14. Greer W. L., Somani A. K., Kwong P. C., Peacocke M., Rubin L. A., Siminovitch K. A. Linkage relationships of the Wiskott-Aldrich syndrome to 10 loci in the pericentromeric region of the human X chromosome. Genomics. 1990 Mar;6(3):568–571. doi: 10.1016/0888-7543(90)90489-h. [DOI] [PubMed] [Google Scholar]
  15. Gröttum K. A., Hovig T., Holmsen H., Abrahamsen A. F., Jeremic M., Seip M. Wiskott-Aldrich syndrome: qualitative platelet defects and short platelet survival. Br J Haematol. 1969 Oct;17(4):373–388. doi: 10.1111/j.1365-2141.1969.tb01383.x. [DOI] [PubMed] [Google Scholar]
  16. Gutenberger J., Trygstad C. W., Stiehm E. R., Opitz J. M., Thatcher L. G., Bloodworth J. M., Jr Familial thrombocytopenia, elevated serum IgA levels and renal disease. A report of a kindred. Am J Med. 1970 Dec;49(6):729–741. doi: 10.1016/s0002-9343(70)80055-9. [DOI] [PubMed] [Google Scholar]
  17. Kenney D., Cairns L., Remold-O'Donnell E., Peterson J., Rosen F. S., Parkman R. Morphological abnormalities in the lymphocytes of patients with the Wiskott-Aldrich syndrome. Blood. 1986 Dec;68(6):1329–1332. [PubMed] [Google Scholar]
  18. Lau Y. L., Shields J. G., Levinsky R. J., Callard R. E. Epstein-Barr-virus-transformed lymphoblastoid cell lines derived from patients with X-linked agammaglobulinaemia and Wiskott-Aldrich syndrome: responses to B cell growth and differentiation factors. Clin Exp Immunol. 1989 Feb;75(2):190–195. [PMC free article] [PubMed] [Google Scholar]
  19. Lum L. G., Tubergen D. G., Corash L., Blaese R. M. Splenectomy in the management of the thrombocytopenia of the Wiskott-Aldrich syndrome. N Engl J Med. 1980 Apr 17;302(16):892–896. doi: 10.1056/NEJM198004173021604. [DOI] [PubMed] [Google Scholar]
  20. Mentzer S. J., Remold-O'Donnell E., Crimmins M. A., Bierer B. E., Rosen F. S., Burakoff S. J. Sialophorin, a surface sialoglycoprotein defective in the Wiskott-Aldrich syndrome, is involved in human T lymphocyte proliferation. J Exp Med. 1987 May 1;165(5):1383–1392. doi: 10.1084/jem.165.5.1383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Morio T., Takase K., Okawa H., Oguchi M., Kanbara M., Hiruma F., Yoshino K., Kaneko T., Asamura S., Inoue T. The increase of non-MHC-restricted cytotoxic cells (gamma/delta-TCR-bearing T cells or NK cells) and the abnormal differentiation of B cells in Wiskott-Aldrich syndrome. Clin Immunol Immunopathol. 1989 Aug;52(2):279–290. doi: 10.1016/0090-1229(89)90179-7. [DOI] [PubMed] [Google Scholar]
  22. Oppenheim J. J., Blaese R. M., Waldmann T. A. Defective lymphocyte transformation and delayed hypersensitivity in Wiskott-Aldrich syndrome. J Immunol. 1970 Apr;104(4):835–844. [PubMed] [Google Scholar]
  23. Parkman R., Rappeport J., Geha R., Belli J., Cassady R., Levey R., Nathan D. G., Rosen F. S. Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation. N Engl J Med. 1978 Apr 27;298(17):921–927. doi: 10.1056/NEJM197804272981701. [DOI] [PubMed] [Google Scholar]
  24. Parkman R., Remold-O'Donnell E., Kenney D. M., Perrine S., Rosen F. S. Surface protein abnormalities in lymphocytes and platelets from patients with Wiskott-Aldrich syndrome. Lancet. 1981 Dec 19;2(8260-61):1387–1389. doi: 10.1016/s0140-6736(81)92802-6. [DOI] [PubMed] [Google Scholar]
  25. Peacocke M., Siminovitch K. A. Linkage of the Wiskott-Aldrich syndrome with polymorphic DNA sequences from the human X chromosome. Proc Natl Acad Sci U S A. 1987 May;84(10):3430–3433. doi: 10.1073/pnas.84.10.3430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Perry G. S., 3rd, Spector B. D., Schuman L. M., Mandel J. S., Anderson V. E., McHugh R. B., Hanson M. R., Fahlstrom S. M., Krivit W., Kersey J. H. The Wiskott-Aldrich syndrome in the United States and Canada (1892-1979). J Pediatr. 1980 Jul;97(1):72–78. doi: 10.1016/s0022-3476(80)80133-8. [DOI] [PubMed] [Google Scholar]
  27. Pidard D., Didry D., Le Deist F., Durandy A., Griscelli C., Bellucci S., Nurden A. T. Analysis of the membrane glycoproteins of platelets in the Wiskott-Aldrich syndrome. Br J Haematol. 1988 Aug;69(4):529–535. doi: 10.1111/j.1365-2141.1988.tb02410.x. [DOI] [PubMed] [Google Scholar]
  28. Piller F., Piller V., Fox R. I., Fukuda M. Human T-lymphocyte activation is associated with changes in O-glycan biosynthesis. J Biol Chem. 1988 Oct 15;263(29):15146–15150. [PubMed] [Google Scholar]
  29. Radl J., Dooren L. H., Morell A., Skvaril F., Vossen J. M., Uittenbogaart C. H. Immunoglobulins and transient paraproteins in sera of patients with the Wiskott-Aldrich syndrome: a follow-up study. Clin Exp Immunol. 1976 Aug;25(2):256–263. [PMC free article] [PubMed] [Google Scholar]
  30. Remold-O'Donnell E., Kenney D. M., Parkman R., Cairns L., Savage B., Rosen F. S. Characterization of a human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome. J Exp Med. 1984 Jun 1;159(6):1705–1723. doi: 10.1084/jem.159.6.1705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Remold-O'Donnell E., Zimmerman C., Kenney D., Rosen F. S. Expression on blood cells of sialophorin, the surface glycoprotein that is defective in Wiskott-Aldrich syndrome. Blood. 1987 Jul;70(1):104–109. [PubMed] [Google Scholar]
  32. Rumelhart S. L., Trigg M. E., Horowitz S. D., Hong R. Monoclonal antibody T-cell-depleted HLA-haploidentical bone marrow transplantation for Wiskott-Aldrich syndrome. Blood. 1990 Feb 15;75(4):1031–1035. [PubMed] [Google Scholar]
  33. Shelley C. S., Remold-O'Donnell E., Davis A. E., 3rd, Bruns G. A., Rosen F. S., Carroll M. C., Whitehead A. S. Molecular characterization of sialophorin (CD43), the lymphocyte surface sialoglycoprotein defective in Wiskott-Aldrich syndrome. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2819–2823. doi: 10.1073/pnas.86.8.2819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Spitler L. E., Wray B. B., Mogerman S., Miller J. J., 3rd, O'Reilly R. J., Lagios M. Nephropathy in the Wiskott-Aldrich syndrome. Pediatrics. 1980 Sep;66(3):391–398. [PubMed] [Google Scholar]
  35. Standen G. R., Lillicrap D. P., Matthews N., Bloom A. L. Inherited thrombocytopenia, elevated serum IgA and renal disease: identification as a variant of the Wiskott-Aldrich syndrome. Q J Med. 1986 Apr;59(228):401–408. [PubMed] [Google Scholar]
  36. Standen G. R., Orchard J. A., Hutton R. D. Wiskott-Aldrich syndrome: fatal consequences of splenectomy in an unrecognised attenuated variant. Br J Clin Pract. 1990 Aug;44(8):338–339. [PubMed] [Google Scholar]
  37. VESTERMARK B., VESTERMARK S. FAMILIAL SEX-LINKED THROMBOCYTOPENIA. Acta Paediatr. 1964 Jul;53:365–370. doi: 10.1111/j.1651-2227.1964.tb07790.x. [DOI] [PubMed] [Google Scholar]
  38. Weiden P. L., Blaese R. M. Hereditary thrombocytopenia: relation to Wiskott-Aldrich syndrome with special reference to splenectomy. Report of a family and review of the literature. J Pediatr. 1972 Feb;80(2):226–234. doi: 10.1016/s0022-3476(72)80583-3. [DOI] [PubMed] [Google Scholar]
  39. de Saint Basile G., Arveiler B., Fraser N. J., Boyd Y., Graig I. W., Griscelli G., Fischer A. Close linkage of hypervariable marker DXS255 to disease locus of Wiskott-Aldrich syndrome. Lancet. 1989 Dec 2;2(8675):1319–1321. doi: 10.1016/s0140-6736(89)91920-x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES